Plasma cell myeloma. An interpretive review.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use; D002455:Cell Division; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D011344:Procarbazine; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone